Ursodeoxycholic acid CAS:128-13-2

Ursodeoxycholic acid (UDCA) has a wide range of medical applications due to its beneficial effects on the liver and gallbladder. One of its primary uses is in the treatment of gallstones, particularly in patients who are not suitable for surgery or for dissolution of cholesterol gallstones. Additionally, UDCA is prescribed to manage certain liver diseases, including primary biliary cholangitis and non-alcoholic fatty liver disease. Its hepatoprotective properties make it effective in improving liver function and reducing liver enzyme levels. Moreover, UDCA has shown promise in treating certain cholestatic liver diseases by promoting bile flow and reducing the accumulation of toxic bile acids. In the field of gastroenterology, UDCA is also utilized to alleviate symptoms of certain digestive disorders, such as chronic cholestasis and biliary reflux gastritis. Furthermore, research suggests that UDCA may have potential therapeutic benefits in preventing and managing colorectal cancer, although further studies are needed to confirm its efficacy in this area. Overall, the versatile applications of Ursodeoxycholic acid make it a valuable pharmaceutical agent in the management of various liver and gastrointestinal conditions.